UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~August 138, 2025 (~~May~~August 8, 2025)

NATIONAL HEALTHCARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation)	001-13489 (Commission File Number)	52-2057472 (I.R.S. Employer Identification No.)
100 Vine Street Murfreesboro, Tennessee (Address of Principal Executive Offices)		37130 (Zip Code)
100 E. Vine Street Murfreesboro, Tennessee (Address of Principal Executive Offices)		37130 (Zip Code)

Registrant’s telephone number, including area code: (615) 890-2020

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.1 par value	NHC	NYSE American
Common Stock, $.01 par value	NHC	NYSE American

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of ~~1933~~1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐

~~Emerging~~If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐

IfITEM an2.02. ~~emerging~~RESULTS ~~growth~~OF ~~company,~~OPERATIONS ~~indicate~~AND byFINANCIAL check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐CONDITION

~~ITEM~~National 5HealthCare Corporation (“NHC”) issued a press release on August 8, 2025, announcing its June 30, 2025 earnings.~~07. SUBMISSION~~ OFThe ~~MATTERS~~entire TOpress Arelease ~~VOTE~~is OFattached ~~SECURITY~~as ~~HOLDERS~~Exhibit 99.1 and is incorporated by reference herein.

~~The~~ITEM ~~Annual Meeting of Shareholders (the “Annual Meeting”) of National HealthCare Corporation (the “Company”) was held on May 8, 2025~~9. ~~As of the record date, March 14, 2025, there were a total of 15,461,829 shares of Common Stock outstanding and entitled to vote at the Annual Meeting~~01. AtFINANCIAL ~~the~~STATEMENTS ~~Annual~~AND ~~Meeting, 12,996,474 shares of Common Stock were represented in person or by proxy; therefore, a quorum was present~~EXHIBITS. ~~The following is a summary of the matters voted upon by the Company's shareholders at the Annual Meeting and the related results:~~

~~1. The Re-election of Stephen F. Flatt, Richard F. LaRoche, and Sandra Y. Trail as directors to each hold office for a three~~ (3d) ~~year term and until their successors have been duly elected and qualified:~~ Exhibits.

		For	Against	Abstain
Exhibit No.	Description of Exhibit
Stephen F. Flatt		12,891,818	94,786	9,870
99.1	Copy of press release issued on August 8, 2025 by National HealthCare Corporation announcing June 30, 2025 earnings.
Richard F. LaRoche		9,670,492	3,319,813	6,169
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)
Sandra Y. Trail		11,718,150	1,265,760	12,564

2. To consider an advisory vote on the compensation of our Named Executive Officers.

For		Against		Abstain
12,498,222		477,555		20,697

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: ~~May~~ August 138, 2025

NATIONAL HEALTHCARE CORPORATION By: /s/ Brian F. Kidd Name: Title: Brian F. Kidd Senior VP/Chief Financial Officer

By: /s/Josh A. McCreary

Name: Josh A. McCreary

Title: Senior Vice President, General Counsel, and Secretary

Filing Compare · NATIONAL HEALTHCARE CORP